171 related articles for article (PubMed ID: 38332912)
1. Autoantibodies against eukaryotic translation elongation factor 1 delta in two patients with autoimmune cerebellar ataxia.
Guo L; Ren H; Fan S; Chao X; Liu M; Guan H; Wang J
Front Immunol; 2023; 14():1289175. PubMed ID: 38332912
[TBL] [Abstract][Full Text] [Related]
2. Septin-3 autoimmunity in patients with paraneoplastic cerebellar ataxia.
Miske R; Scharf M; Borowski K; Rieckhoff N; Teegen B; Denno Y; Probst C; Guthke K; Didrihsone I; Wildemann B; Ruprecht K; Komorowski L; Jarius S
J Neuroinflammation; 2023 Mar; 20(1):88. PubMed ID: 36997937
[TBL] [Abstract][Full Text] [Related]
3. Neurochondrin Antibody Serum Positivity in Three Cases of Autoimmune Cerebellar Ataxia.
Weihua Z; Haitao R; Fang F; Xunzhe Y; Jing W; Hongzhi G
Cerebellum; 2019 Dec; 18(6):1137-1142. PubMed ID: 31179511
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody against the Rab6A/Rab6B in primary autoimmune cerebellar ataxia associated with Sjogren's syndrome: A case report.
Guo L; Ren H; Fan S; Guan H; Wang J
J Neuroimmunol; 2021 Oct; 359():577667. PubMed ID: 34332492
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia.
Damato V; Papi C; Spagni G; Evoli A; Silvestri G; Masi G; Sabatelli E; Campetella L; McKeon A; Andreetta F; Riso V; Monte G; Luigetti M; Primiano G; Calabresi P; Iorio R
Eur J Neurol; 2022 Feb; 29(2):564-572. PubMed ID: 34710286
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of an anti-mouse cerebellar tissue-derived antigen antibody test in predicting immunotherapy efficacy in patients with idiopathic cerebellar ataxia].
Ohtomo T; Ogino S; Yanai S; Nakayama S; Yajima R; Sugawara M; Yamada J; Aizawa H; Taguchi T; Nanri K
Rinsho Shinkeigaku; 2022 Feb; 62(2):112-122. PubMed ID: 35095045
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.
Liu M; Ren H; Zhu Y; Fan S; Bai L; Wang J; Cui L; Guan H
Cerebellum; 2023 Jun; 22(3):379-385. PubMed ID: 35618871
[TBL] [Abstract][Full Text] [Related]
8. Anti-Tr/DNER antibody-associated cerebellar ataxia: three rare cases report and literature review.
Cai Y; Liu J; Ren H; Shi F; Che J; Geng Q; Tan Y; Guan H; Di W
Neurol Sci; 2023 Jan; 44(1):397-403. PubMed ID: 36094774
[TBL] [Abstract][Full Text] [Related]
9. Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature.
Jarius S; Bräuninger S; Chung HY; Geis C; Haas J; Komorowski L; Wildemann B; Roth C
J Neuroinflammation; 2022 Jul; 19(1):196. PubMed ID: 35907972
[TBL] [Abstract][Full Text] [Related]
10. Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia.
Jarius S; Martínez-García P; Hernandez AL; Brase JC; Borowski K; Regula JU; Meinck HM; Stöcker W; Wildemann B; Wandinger KP
J Neuroinflammation; 2013 Jan; 10():7. PubMed ID: 23320754
[TBL] [Abstract][Full Text] [Related]
11. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
[TBL] [Abstract][Full Text] [Related]
12. [Approach from a Perspective of Autoimmune Cerebellar Ataxia].
Yoshikura N; Kimura A; Takekoshi A; Shimohata T
Brain Nerve; 2020 Sep; 72(9):961-967. PubMed ID: 32934185
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.
Jarius S; Scharf M; Begemann N; Stöcker W; Probst C; Serysheva II; Nagel S; Graus F; Psimaras D; Wildemann B; Komorowski L
J Neuroinflammation; 2014 Dec; 11():206. PubMed ID: 25498830
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies.
Yoshikura N; Kimura A; Fukata M; Fukata Y; Yokoi N; Harada N; Hayashi Y; Inuzuka T; Shimohata T
J Neuroimmunol; 2018 Jun; 319():63-67. PubMed ID: 29685291
[TBL] [Abstract][Full Text] [Related]
15. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():168. PubMed ID: 26377319
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.
Nanri K; Okuma M; Sato S; Yoneda M; Taguchi T; Mitoma H; Yamada J; Unezaki S; Nagatani T; Otsubo S; Sugawara M; Tanaka N; Mizusawa H
Intern Med; 2016; 55(5):449-54. PubMed ID: 26935362
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune Cerebellar Ataxia Associated with Anti-Glutamate Receptor δ2 Antibodies: a Rare but Treatable Entity.
Khatib L; Do LD; Benaiteau M; Villagrán-García M; Scharf M; Meyer P; Haidar LA; Demeret S; Honnorat J
Cerebellum; 2024 Feb; 23(1):260-266. PubMed ID: 36696031
[TBL] [Abstract][Full Text] [Related]
18. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
[TBL] [Abstract][Full Text] [Related]
19. Neurological Autoimmunity Associated With Homer-3 Antibody: A Case Series From China.
Liu M; Ren H; Fan S; Zhang W; Xu Y; Zhao W; Guan H;
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34580182
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution.
Kudo A; Yaguchi H; Tanaka K; Kimura A; Yabe I
J Neurol; 2024 Jan; 271(1):553-563. PubMed ID: 37610447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]